319927-24-7 Usage
Uses
Used in Pharmaceutical Research:
H-D-MET-MET-MET-OH is used as a research compound for exploring its potential biological activities and therapeutic benefits. Its interaction with enzymes, receptors, and other molecules in the body makes it a valuable tool for understanding various biochemical pathways.
Used in Antioxidant Applications:
H-D-MET-MET-MET-OH is used as an antioxidant agent, potentially protecting cells from oxidative stress and damage. Its antioxidant properties may contribute to the prevention of various diseases and conditions associated with oxidative stress.
Used in Anti-inflammatory Applications:
H-D-MET-MET-MET-OH is used as an anti-inflammatory agent, potentially reducing inflammation and associated symptoms. Its anti-inflammatory properties may be beneficial in the treatment of various inflammatory conditions.
Used in Anticancer Applications:
H-D-MET-MET-MET-OH is used as an anticancer agent, potentially inhibiting the growth and progression of cancer cells. Its anti-cancer properties may make it a valuable component in the development of new cancer therapies.
Used in Drug Development:
H-D-MET-MET-MET-OH is used as a potential drug candidate in the development of new therapeutic agents. Its diverse biological activities and potential health benefits make it an attractive target for pharmaceutical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 319927-24-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,9,9,2 and 7 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 319927-24:
(8*3)+(7*1)+(6*9)+(5*9)+(4*2)+(3*7)+(2*2)+(1*4)=167
167 % 10 = 7
So 319927-24-7 is a valid CAS Registry Number.
319927-24-7Relevant academic research and scientific papers
A novel L-amino acid ligase from bacillus subtilis NBRC3134 catalyzed oligopeptide synthesis
Kino, Kuniki,Arai, Toshinobu,Tateiwa, Daisuke
experimental part, p. 129 - 134 (2010/04/24)
L-Amino acid ligase catalyzes dipeptide synthesis from unprotected L-amino acids in an ATP-dependent manner. We have purified a new L-amino acid ligase, RizA, which synthesizes dipeptides whose N-terminus is Arg, from Bacillus subtilis NBRC3134, a microorganism that produces a rhizocticin peptide antibiotic. It was suggested that RizA is probably involved in rhizocticin biosynthesis. In this study, we performed sequence analysis of unknown regions around rizA, and newly identified a gene that encodes a protein that possesses an ATP-grasp motif upstream of rizA. This gene was designated rizB, and its recombinant protein was prepared. Recombinant RizB synthesized homo-oligo-mers of branched-chain L-amino acids and L-methionine consisting of two to five amino acids in an ATP-dependent manner. RizB also synthesized various heteropeptides. Further examination showed that RizB might elongate a peptide chain at the N-terminus. This is the first report on an L-amino acid ligase catalyzing oligopeptide synthesis.
